NCT00687232 Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers Status COMPLETED Phase PHASE1
NCT00687141 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects Status COMPLETED Phase PHASE1
NCT00686946 The National Register of Antipsychotic Medication in Pregnancy (NRAMP) Status RECRUITING Phase N/A
NCT00686504 Positron Emission Tomography (PET) Study With [11C]AZ12713580 to Determine Central mGluR5 Receptor Occupancy of AZD2066 Status COMPLETED Phase PHASE1
NCT00686413 Positron Emission Tomography Study Using 2-[18F]-F-A85380 to Determine α4β2 Neuronal Nicotinic Receptor Occupancy of AZD3480 After Oral Administration to Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT00686179 Investigate the Effect on the QT/QTc Interval of Repeated and Escalating Doses of AZD3480 During 6 Days Status COMPLETED Phase PHASE1
NCT00684502 Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy Subjects Status COMPLETED Phase PHASE1
NCT00684385 An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck Status APPROVED_FOR_MARKETING Phase N/A
NCT00684307 Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation Status COMPLETED Phase PHASE2
NCT00684151 Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in Thailand Status COMPLETED Phase N/A
NCT00683657 Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone Status COMPLETED Phase PHASE3
NCT00683618 Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT00683462 An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD) Status COMPLETED Phase PHASE2
NCT00683306 Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment Status APPROVED_FOR_MARKETING Phase N/A
NCT00681967 Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer Status COMPLETED Phase PHASE1